There is no correlation between c-Myc mRNA expression and telomerase activity in human breast cancer
- PMID: 15285810
- PMCID: PMC483032
- DOI: 10.1186/1477-7800-1-2
There is no correlation between c-Myc mRNA expression and telomerase activity in human breast cancer
Abstract
BACKGROUND: Telomerase is a ribonucleoprotein enzyme that synthesises telomeres after cell division and maintains chromosomal length and stability thus leading to cellular immortalisation. The hTERT (human telomerase reverse transcriptase) subunit seems to be the rate-limiting determinant of telomerase and knowledge of factors controlling hTERT transcription may be useful in therapeutic strategies. The hTERT promoter contains binding sites for c-Myc and there is experimental and in vitro evidence that c-Myc may increase hTERT expression. MATERIALS AND METHODS: RNA was extracted from 18 breast carcinomas and c-Myc mRNA expression was estimated by quantitative reverse transcriptase-PCR (RT-PCR) with Taqman methodology. These tumours had already been analysed for ER and PgR status using ligand-binding assays and had had their DNA ploidy and S-phase fractions measured by flow cytometry. Telomerase activity had already been determined by using a modified telomeric repeat and amplification protocol (TRAP) assay. RESULTS: Telomerase activity ranged from 0 to 246 units of Total Protein Generated (TPG), where one unit of TPG was equal to 600 molecules of telomerase substrate primers extended by at least three telomeric repeats. Median levels of TPG were 60 and mean levels 81. There was no significant correlation between levels of c-Myc mRNA expression, telomerase activity, S phase fraction or PgR. There was a significant negative correlation with ER status. CONCLUSION: Although the hTERT promoter contains potential binding sites for c-Myc oncoprotein, we have found no correlation between c-Myc mRNA levels and telomerase activity.
Figures
Similar articles
-
hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer.J Carcinog. 2005 Oct 4;4:17. doi: 10.1186/1477-3163-4-17. J Carcinog. 2005. PMID: 16202165 Free PMC article.
-
hTERT mRNA expression correlates with telomerase activity in human breast cancer.Eur J Surg Oncol. 2003 May;29(4):321-6. doi: 10.1053/ejso.2002.1374. Eur J Surg Oncol. 2003. PMID: 12711283
-
hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression.Breast Cancer Res Treat. 2003 Feb;77(3):277-84. doi: 10.1023/a:1021849217054. Breast Cancer Res Treat. 2003. PMID: 12602927
-
Telomerase activity in cancer as a diagnostic and therapeutic target.Histol Histopathol. 2000 Jul;15(3):813-24. doi: 10.14670/HH-15.813. Histol Histopathol. 2000. PMID: 10963125 Review.
-
Telomeres, telomerase, and myc. An update.Mutat Res. 2000 Jan;462(1):31-47. doi: 10.1016/s1383-5742(99)00091-5. Mutat Res. 2000. PMID: 10648922 Review.
Cited by
-
hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer.J Carcinog. 2005 Oct 4;4:17. doi: 10.1186/1477-3163-4-17. J Carcinog. 2005. PMID: 16202165 Free PMC article.
-
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.Genes (Basel). 2016 Aug 18;7(8):50. doi: 10.3390/genes7080050. Genes (Basel). 2016. PMID: 27548225 Free PMC article. Review.
-
Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC.Front Cell Dev Biol. 2017 Jan 26;5:1. doi: 10.3389/fcell.2017.00001. eCollection 2017. Front Cell Dev Biol. 2017. PMID: 28184371 Free PMC article. Review.
References
-
- Kim N, Piatyszek MA, Prowse K. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011–2015. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials